Mitchell H. Gold
2017
In 2017, Mitchell H. Gold earned a total compensation of $2.4M as Executive Chairman and Chief Executive Officer at Nivalis Therapeutics, a 1,843% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,056,322 |
|---|---|
| Salary | $300,000 |
| Other | $3,060 |
| Total | $2,359,382 |
Gold received $2.1M in option awards, accounting for 87% of the total pay in 2017.
Gold also received $300K in salary and $3.1K in other compensation.
Rankings
In 2017, Mitchell H. Gold's compensation ranked 4,709th out of 14,666 executives tracked by ExecPay. In other words, Gold earned more than 67.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,709 out of 14,666 | 68th |
Division Manufacturing | 1,661 out of 5,772 | 71st |
Major group Chemicals And Allied Products | 485 out of 2,075 | 77th |
Industry group Drugs | 373 out of 1,731 | 79th |
Industry Pharmaceutical Preparations | 295 out of 1,333 | 78th |
Source: SEC filing on April 24, 2018.
Gold's colleagues
We found five more compensation records of executives who worked with Mitchell H. Gold at Nivalis Therapeutics in 2017.
2017
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
2017
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
2017
Jon Congleton
Nivalis Therapeutics
Chief Executive Officer
2017
Stanford Peng
Nivalis Therapeutics
Chief Medical Officer
2017
Paul Rickey
Nivalis Therapeutics